“Eva Lindskog has extensive experience in the life sciences industry and across the biopharmaceutical value chain,” says Peter von Ehrenheim, Chairman of the Board at Bio-Works. “She combines deep industry expertise with a strong track record in building commercial capabilities and driving growth. We are convinced that her experience, leadership, and commercial focus make her well suited to lead Bio-Works through its next phase.”

Eva Lindskog

Eva Lindskog has more than 15 years of experience in senior life sciences roles, with a focus on bioprocessing, contract manufacturing, and analytical technologies. She currently serves as Chief Commercial Officer at NanoTemper Technologies and has previously held senior positions at Sartorius, Lonza, and GE Healthcare Life Sciences, now Cytiva. She holds an MSc in Chemical Engineering and a PhD in Bioprocess Technology from KTH Royal Institute of Technology.

“Bio-Works has a solid technical foundation, clearly differentiated products, and a highly committed team,” Lindskog says. “Continued success will depend on further strengthening our customer relationships. I intend to lead that work and engage directly with end users to ensure that the value of our products is fully understood.”

Lindskog will step down from Bio-Works’ Board of Directors in connection with her appointment.